Mirae Asset Global Investments Co., Ltd. Macrogenics Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Macrogenics Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,100 shares of MGNX stock, worth $3,654. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,100
Previous 2,091
0.43%
Holding current value
$3,654
Previous $6,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding MGNX
# of Institutions
133Shares Held
54MCall Options Held
45.1KPut Options Held
143K-
Bellevue Group Ag Kuesnacht, V89.93MShares$17.3 Million0.29% of portfolio
-
Armistice Capital, LLC New York, NY6.3MShares$11 Million0.12% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$9.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$7.7 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$5.66 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $107M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...